Drugs / Sodium monoflurophosphate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01657877 | May 2012 → Jun 2013 | dental caries | GlaxoSmithKline | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01128972 Comparator | Aug → Oct 2009 | tooth disorder | GlaxoSmithKline | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium monoflurophosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01657877 ↗ |